Type II CRISPR/Cas9 approach in the oncological therapy

Type II CRISPR/Cas9 approach in the oncological therapy

Abstract CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a prokaryotic adaptable immune mechanism used by many bacteria and archaea to protect themselves from foreign nucleic acids. This complex system can recognize and cut non-self DNA in order to provide the prokaryotic organ...

Full description

Bibliographic Details
Main Authors: A. Biagioni, A. Chillà, E. Andreucci, A. Laurenzana, F. Margheri, S. Peppicelli, M. Del Rosso, G. Fibbi
Format: Article
Language:English
Published: BMC 2017-06-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
CRISPR
Gene therapy
Gene delivery
Genetic engineering
Immune therapy
Oncology
Online Access:http://link.springer.com/article/10.1186/s13046-017-0550-0

Internet

http://link.springer.com/article/10.1186/s13046-017-0550-0

Similar Items